Literature DB >> 30070567

Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder.

Julianne C Flanagan1, Anne Hand2, Amber M Jarnecke1, Megan M Moran-Santa Maria1, Kathleen T Brady1, Jane E Joseph2.   

Abstract

Posttraumatic stress disorder (PTSD) is a chronic, debilitating condition for which effective medications are scant and little is known about neural correlates of risk versus resilience. Oxytocin is a hypothalamic neuropeptide that has demonstrated promise in modulating neurobiological and behavioral correlates of PTSD. Cognitive deficits in areas such as working memory and executive control are highly prevalent among individuals with PTSD and oxytocin might modulate these impairments in individuals with PTSD. Using a double-blind, placebo-controlled design, this study employed functional MRI (fMRI) and the n-back working memory task to examine the effects of oxytocin (24 IU) versus placebo on working memory and dorsolateral prefrontal cortex (DLPFC) connectivity among individuals with PTSD (n = 16) as compared with a trauma-exposed control group (n = 18). Results indicate that individuals with PTSD on oxytocin performed better in the 2-back condition of the n-back task compared with individuals with PTSD on placebo. Results also indicate that connectivity between DLPFC and anterior cingulate increased in the 2-back condition among individuals with PTSD on oxytocin as compared with placebo. These findings provide preliminary evidence of an effect of oxytocin on working memory among individuals with PTSD and insights into the neurobiological mechanisms underlying this association. Future studies are necessary to understand the mechanisms responsible for working memory deficits in PTSD and to examine the potential of oxytocin for use as a treatment for PTSD. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30070567      PMCID: PMC6075739          DOI: 10.1037/pha0000197

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  76 in total

1.  Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET.

Authors:  P A Reuter-Lorenz; J Jonides; E E Smith; A Hartley; A Miller; C Marshuetz; R A Koeppe
Journal:  J Cogn Neurosci       Date:  2000-01       Impact factor: 3.225

2.  Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.

Authors:  Mirjam van Zuiden; Jessie L Frijling; Laura Nawijn; Saskia B J Koch; J Carel Goslings; Jan S Luitse; Tessa H Biesheuvel; Adriaan Honig; Dick J Veltman; Miranda Olff
Journal:  Biol Psychiatry       Date:  2016-12-08       Impact factor: 13.382

3.  Neurocognitive Correlates of Successful Treatment of PTSD in Female Veterans.

Authors:  Kathleen Y Haaland; Joseph R Sadek; Jenna E Keller; Diane T Castillo
Journal:  J Int Neuropsychol Soc       Date:  2016-06-06       Impact factor: 2.892

4.  Hormonal contraceptives suppress oxytocin-induced brain reward responses to the partner's face.

Authors:  Dirk Scheele; Jessica Plota; Birgit Stoffel-Wagner; Wolfgang Maier; René Hurlemann
Journal:  Soc Cogn Affect Neurosci       Date:  2015-12-31       Impact factor: 3.436

5.  Exposure to childhood trauma is associated with altered n-back activation and performance in healthy adults: implications for a commonly used working memory task.

Authors:  Noah S Philip; Lawrence H Sweet; Audrey R Tyrka; S Louisa Carpenter; Sarah E Albright; Lawrence H Price; Linda L Carpenter
Journal:  Brain Imaging Behav       Date:  2016-03       Impact factor: 3.978

6.  Effects of intranasal oxytocin on emotional face processing in women.

Authors:  Gregor Domes; Alexander Lischke; Christoph Berger; Annette Grossmann; Karlheinz Hauenstein; Markus Heinrichs; Sabine C Herpertz
Journal:  Psychoneuroendocrinology       Date:  2010-01       Impact factor: 4.905

7.  Male veterans with PTSD exhibit aberrant neural dynamics during working memory processing: an MEG study.

Authors:  Timothy J McDermott; Amy S Badura-Brack; Katherine M Becker; Tara J Ryan; Maya M Khanna; Elizabeth Heinrichs-Graham; Tony W Wilson
Journal:  J Psychiatry Neurosci       Date:  2016-06       Impact factor: 6.186

Review 8.  Pharmacological treatment of comorbid PTSD and substance use disorder: recent progress.

Authors:  Mehmet Sofuoglu; Robert Rosenheck; Ismene Petrakis
Journal:  Addict Behav       Date:  2013-08-22       Impact factor: 3.913

9.  Neuroimaging resilience to stress: a review.

Authors:  S J A van der Werff; S M van den Berg; J N Pannekoek; B M Elzinga; N J A van der Wee
Journal:  Front Behav Neurosci       Date:  2013-05-07       Impact factor: 3.558

10.  Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene.

Authors:  Caroline M Nievergelt; Adam X Maihofer; Maja Mustapic; Kate A Yurgil; Nicholas J Schork; Mark W Miller; Mark W Logue; Mark A Geyer; Victoria B Risbrough; Daniel T O'Connor; Dewleen G Baker
Journal:  Psychoneuroendocrinology       Date:  2014-10-30       Impact factor: 4.693

View more
  8 in total

1.  Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial.

Authors:  Julianne C Flanagan; Jennifer M Mitchell; Nathaniel L Baker; Joshua Woolley; Bethany Wangelin; Sudie E Back; John R McQuaid; Thomas C Neylan; William R Wolfe; Kathleen T Brady
Journal:  Contemp Clin Trials       Date:  2020-06-16       Impact factor: 2.226

2.  Dorsolateral prefrontal cortex sensing analgesia.

Authors:  Etsuro Ito; Kotaro Oka; Fusako Koshikawa
Journal:  Biophys Physicobiol       Date:  2022-04-08

Review 3.  Pharmacotherapy for post traumatic stress disorder (PTSD).

Authors:  Taryn Williams; Nicole J Phillips; Dan J Stein; Jonathan C Ipser
Journal:  Cochrane Database Syst Rev       Date:  2022-03-02

4.  Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex.

Authors:  Alex D Klausing; Tsutomu Fukuwatari; David J Bucci; Robert Schwarcz
Journal:  Psychopharmacology (Berl)       Date:  2020-03-25       Impact factor: 4.530

5.  Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin.

Authors:  Julianne C Flanagan; Jennifer M Mitchell
Journal:  Curr Treat Options Psychiatry       Date:  2019-04-29

6.  Impact of Oxytocin on the neural correlates of fearful face processing in PTSD related to childhood Trauma.

Authors:  Julianne C Flanagan; Lauren M Sippel; Megan M Moran Santa Maria; Karen J Hartwell; Kathleen T Brady; Jane E Joseph
Journal:  Eur J Psychotraumatol       Date:  2019-05-07

7.  Effects of Oxytocin on Fear Memory and Neuroinflammation in a Rodent Model of Posttraumatic Stress Disorder.

Authors:  Sheng-Chiang Wang; Chen-Cheng Lin; Chun-Chuan Chen; Nian-Sheng Tzeng; Yia-Ping Liu
Journal:  Int J Mol Sci       Date:  2018-12-03       Impact factor: 5.923

Review 8.  The oxytocinergic system in PTSD following traumatic childbirth: endogenous and exogenous oxytocin in the peripartum period.

Authors:  A B Witteveen; C A I Stramrood; J Henrichs; J C Flanagan; M G van Pampus; M Olff
Journal:  Arch Womens Ment Health       Date:  2019-08-06       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.